Walleye Capital LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 94 filers reported holding RECRO PHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2023$67,015
-93.3%
56,315
-91.6%
0.00%
-94.4%
Q4 2022$1,003,029
+934.1%
673,174
+3049.5%
0.02%
-18.2%
Q2 2020$97,000
-16.4%
21,374
+50.2%
0.02%
-15.4%
Q1 2020$116,00014,2310.03%
Other shareholders
RECRO PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders